GlassScriptPhysician profile
Neha Potini
NPI 1285933051
$795.10
in general payments reported to CMS, 2019-2025
18 companies · $209 in 2025
The $209 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.83 · 2020: $15.32 · 2021: $32.38 · 2022: $27.52 · 2023: $137 · 2024: $347 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $144.72 | 2024-2025 | |
| Pfizer INC. | $127.14 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $102.38 | 2023-2024 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $60.02 | 2019-2024 | |
| Ironshore Pharmaceuticals INC. | $55.47 | 2023-2024 | Jornay Pm |
| Corium, LLC | $49.08 | 2023-2024 | Azstarys |
| Collegium Pharmaceutical, INC. | $35.76 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $33.66 | 2022-2023 | Pediarix, Bexsero, Menveo |
| Vertical Pharmaceuticals, LLC | $29.38 | 2025 | Relexxii |
| Verrica Pharmaceuticals INC. | $26.19 | 2024 | Ycanth |
| Genzyme Corporation | $23.26 | 2024 | |
| Rhythm Pharmaceuticals, INC. | $18.58 | 2024 | Imcivree |
| Kaleo, INC. | $17.52 | 2021 | |
| Novo Nordisk INC | $16.46 | 2025 | Wegovy |
| Cranial Technologies, INC | $15.32 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $14.86 | 2021 | |
| Neos Therapeutics, LP | $13.15 | 2019 | |
| Merck Sharp & Dohme LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Potini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.